http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005085195-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_065fe7c4146d471ac47823ff7c1d911f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a4e1b1f2b34b9dad147f7923ec7305d5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fc5569b8054d40e9103baa9ffc4e7f0a
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4045
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D209-08
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4045
filingDate 2005-02-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ca77a299b32537df73f3728542dfb818
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5046ce585b232d56ad9052dec50c69d7
publicationDate 2005-09-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2005085195-A1
titleOfInvention Medicinal composition for prevention or treatment of overactive bladder accompanying nervous disorder
abstract A medicinal composition for the prevention or treatment of overactive bladder accompanying nervous disorders. The medicinal composition contains as an active ingredient an indoline derivative represented by the following general formula (I) or a pharmacologically acceptable salt thereof. The medicinal composition is useful in the prevention or treatment of overactive bladder accompanying nervous disorders such as cerebrovascular disorder, Parkinson's disease, and myelopathia. In the formula, R represents optionally substituted aliphatic acyl, optionally substituted lower alkyl, optionally substituted aromatic acyl, etc.; R1 represents cyano or carbamoyl; and R2 represents optionally substituted lower alkyl.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1806136-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1806136-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1800677-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1800677-A4
priorityDate 2004-03-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004054574-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-1432007-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H06220015-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004022538-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2000247998-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2001288115-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9948530-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9915202-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2002143007-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397365
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506064
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419580795
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454973655
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419890815
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11548
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226397247
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419591129
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128521020
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457461622
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420878335
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6938
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1031
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID49935
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11868
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4737
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454110861
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3354
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID443879
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420789664
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10328
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412613347
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393705
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449071750
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8420
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394811
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID27522
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396411
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457484986
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393368
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396401
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419476471
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4942
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535600

Total number of triples: 79.